I. Bieche

发表

The prognosis of patients treated with everolimus for advanced ER‐positive, HER2‐negative breast cancer is driven by molecular features

A. Vincent-Salomon, P. Cottu, A. Schnitzler, 2024, The journal of pathology. Clinical research.

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.

E. Rouleau, C. Westphalen, A. Bayle, 2024, Annals of oncology : official journal of the European Society for Medical Oncology.

Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial

D. Stoppa-Lyonnet, C. Callens, S. Cecere, 2023, Oncogene.